Effect of piracetam in preventing delirium in ICU patients
Phase 3
Recruiting
- Conditions
- Delirium.Delirium due to known physiological condition
- Registration Number
- IRCT20240105060618N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age 18 to 80
Consent to participate
Medical ICU case
Exclusion Criteria
Pregnancy
COVID-19 patients
Surgical and burn ICU cases
APACHE score >28 in the ICU admission
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Delirium (positive confusion assessment method). Timepoint: The first 7 days of ICU admission. Method of measurement: Confusion assessment method.
- Secondary Outcome Measures
Name Time Method